In this article, we will be taking a look at the 7 best dialysis and kidney disease stocks to buy. Global Kidney Treatment and Dialysis Market: Rapid Growth Amid Rising Prevalence of Kidney Disease The global kidney treatment and dialysis market is experiencing typical growth levels. According to Allied Market Research, in 2020, the market […]
Abbott Laboratories and Johnson & Johnson both have raised their dividends annually for more than 50 years.
Based on the average brokerage recommendation (ABR), Abbott (ABT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?